Phenotypes of complement knockouts

Ahearn, 1996, Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen, Immunity, 4, 251, 10.1016/S1074-7613(00)80433-1 Arnett, 1992, Genetic aspects of human lupus, Clin. Immunol. Immunopathol, 63, 4, 10.1016/0090-1229(92)90082-Y Atkinson, 1989, Complement deficiency: predisposing factor to autoimmune syndromes, Clin. Exp. Rheum., 7, 95 Bickerstaff, 1999, Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity, Nat. Med., 5, 694, 10.1038/9544 Botto, 1998, Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies, Nat. Genet., 19, 56, 10.1038/ng0598-56 Bowness, 1994, Hereditary C1q deficiency and systemic lupus erythematosus, Q. J. Med., 87, 455 Circolo, 1999, Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic C3 mRNA, Immunopharmacology, 42, 135, 10.1016/S0162-3109(99)00021-1 Da Costa, 1999, Humoral response to herpes simplex virus is complement dependent, Proc. Natl. Acad. Sci. U. S. A., 96, 12708, 10.1073/pnas.96.22.12708 Dalmasso, 1986, Complement in the pathophysiology and diagnosis of human diseases, CRC Crit. Rev. Clin. Lab. Sci., 24, 123, 10.3109/10408368609110272 Davoust, 1999, Central nervous system-targeted expression of the complement inhibitors Crry prevents experimental allergic encephalomyelitis, J. Immunol., 163, 6551, 10.4049/jimmunol.163.12.6551 Fang, 1998, Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response, J. Immunol., 160, 5273, 10.4049/jimmunol.160.11.5273 Fearon, 1995, The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity, Annu. Rev. Immunol., 13, 127, 10.1146/annurev.iy.13.040195.001015 Figueroa, 1991, Infectious diseases associated with complement deficiencies, Clin. Microbiol. Rev., 4, 359, 10.1128/CMR.4.3.359 Fischer, 1996, Regulation of the B cell response to T-dependent antigens by classical pathway of complement, J. Immunol., 157, 549, 10.4049/jimmunol.157.2.549 Fischer, 1997, Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement, J. Immunol., 159, 976, 10.4049/jimmunol.159.2.976 Fischer, 1998, Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3 deficient mice, J. Immunol., 160, 2619, 10.4049/jimmunol.160.6.2619 Fischer, 1998, Dependence of germinal center B cells on expression of CD21/CD35 for survival, Science, 280, 582, 10.1126/science.280.5363.582 Gewurz, 1996, Structure and function of the pentraxins, Curr. Opin. Immunol., 7, 54, 10.1016/0952-7915(95)80029-8 Hopken, 1996, The C5a chemoattractant receptor mediates mucosal defence to infection, Nature, 383, 86, 10.1038/383086a0 Hopken, 1997, Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor, J. Exp. Med., 185, 749, 10.1084/jem.186.5.749 Kim, 1995, Mouse complement regulatory protein Crry/p65 utilizes the specific mechanisms of both decay-accelerating factor and membrane cofactor protein, J. Exp. Med., 181, 151, 10.1084/jem.181.1.151 Kinoshita, 1990, Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor, Int. Immunol., 2, 651, 10.1093/intimm/2.7.651 Korb, 1997, C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes, J. Immunol., 158, 4525, 10.4049/jimmunol.158.10.4525 Kozono, 1998, Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells, J. Immunol., 160, 1565, 10.4049/jimmunol.160.4.1565 Kurtz, 1990, The murine complement receptor gene family: IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1, J. Immunol., 144, 3581, 10.4049/jimmunol.144.9.3581 Matsumoto, 1997, Abrogation of the alternative complement pathway by targeted deletion of murine factor B, Proc. Natl. Acad. Sci. U. S. A., 94, 8720, 10.1073/pnas.94.16.8720 Mitchell, 1999, C1q protects against the development of glomerulonephritis independently of C3 activation, J. Immunol., 162, 5676, 10.4049/jimmunol.162.10.5676 Molina, 1990, A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2, J. Immunol., 145, 2974, 10.4049/jimmunol.145.9.2974 Molina, 1992, Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologs of human CR1, J. Exp. Med., 175, 121, 10.1084/jem.175.1.121 Molina, 1996, Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2, Proc. Natl. Acad. Sci. U. S. A., 93, 3357, 10.1073/pnas.93.8.3357 Prodeus, 1999, A critical role for complement in maintenance of self-tolerance, Immunity, 9, 721, 10.1016/S1074-7613(00)80669-X Quigg, 1998, Immune complex glomerulonephritis in C4- and C3-deficient mice, Kidney Int., 53, 320, 10.1046/j.1523-1755.1998.00723.x Quigg, 1998, Transgenic mice overexpressing the complement inhibitor Crry as a soluble protein are protected from antibody-induced glomerular injury, J. Exp. Med., 188, 1321, 10.1084/jem.188.7.1321 Quigg, 1998, Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor, J. Immunol., 160, 4553, 10.4049/jimmunol.160.9.4553 Spicer, 1995, Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes, J. Immunol., 155, 3079, 10.4049/jimmunol.155.6.3079 Sun, 1999, Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting, Proc. Nat. Acad. Sci. U. S. A., 92, 628, 10.1073/pnas.96.2.628 Taylor, 1998, A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2 and D17H6S45, J. Biol. Chem., 273, 1699, 10.1074/jbc.273.3.1699 Tedder, 1994, The CD19/CD21 signal transduction complex of B lymphocytes, Immunol. Today, 15, 437, 10.1016/0167-5699(94)90274-7 Walport, 1988, Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases, Arthritis Rheum., 31, 153, 10.1002/art.1780310201 Watanabe, 2000, Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor, B.J. Immunol., 164, 786, 10.4049/jimmunol.164.2.786 Wessels, 1995, Studies of group B streptococcal infection in mice deficient in complement C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity, Proc. Natl. Acad. Sci. U. S. A., 92, 11490, 10.1073/pnas.92.25.11490 Wetsel, 1995, Structure, function and cellular expression of complement anaphylatoxin receptors, Curr. Opin. Immunol., 7, 48, 10.1016/0952-7915(95)80028-X Wilson, 1986, Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus, Arthritis Rheum., 29, 739, 10.1002/art.1780290606 Xu, 2000, A critical role for murine complement regulator Crry in fetomaternal tolerance, Science, 287, 498, 10.1126/science.287.5452.498